tiprankstipranks
Trending News
More News >
iSpecimen (ISPC)
NASDAQ:ISPC
US Market
Advertisement

iSpecimen (ISPC) Stock Forecast & Price Target

Compare
163 Followers
See the Price Targets and Ratings of:

ISPC Financial Forecast

ISPC Earnings Forecast

The previous quarter’s earnings for ISPC were -$0.71.
The previous quarter’s earnings for ISPC were -$0.71.

ISPC Sales Forecast

The previous quarter’s earnings for ISPC were $1.06M.
The previous quarter’s earnings for ISPC were $1.06M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ISPC
TipRanks AITipRanks
Not Ranked
TipRanks
$1
Sell
-7.41%
Downside
Reiterated
07/17/25
iSpecimen's overall stock score reflects severe financial weaknesses, highlighted by declining revenues and persistent losses. The technical analysis suggests weak market momentum, and valuation metrics are unattractive due to negative earnings. Furthermore, the Nasdaq non-compliance notice exacerbates risks, potentially affecting future stability and market perception.
Craig-Hallum Analyst forecast on ISPC
Matt HewittCraig-Hallum
Craig-Hallum
Buy
Reiterated
08/07/24
iSpecimen (ISPC) Gets a Buy from Craig-Hallum
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ISPC
TipRanks AITipRanks
Not Ranked
TipRanks
$1
Sell
-7.41%
Downside
Reiterated
07/17/25
iSpecimen's overall stock score reflects severe financial weaknesses, highlighted by declining revenues and persistent losses. The technical analysis suggests weak market momentum, and valuation metrics are unattractive due to negative earnings. Furthermore, the Nasdaq non-compliance notice exacerbates risks, potentially affecting future stability and market perception.
Craig-Hallum Analyst forecast on ISPC
Matt HewittCraig-Hallum
Craig-Hallum
Buy
Reiterated
08/07/24
iSpecimen (ISPC) Gets a Buy from Craig-Hallum
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering iSpecimen

1 Month
xxx
Success Rate
3/13 ratings generated profit
23%
Average Return
-11.52%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 23.08% of your transactions generating a profit, with an average return of -11.52% per trade.
3 Months
xxx
Success Rate
3/13 ratings generated profit
23%
Average Return
-21.25%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 23.08% of your transactions generating a profit, with an average return of -21.25% per trade.
1 Year
Matt HewittCraig-Hallum
Success Rate
0/13 ratings generated profit
0%
Average Return
-67.08%
reiterated a buy rating 12 months ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -67.08% per trade.
2 Years
xxx
Success Rate
0/13 ratings generated profit
0%
Average Return
-77.92%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -77.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISPC Analyst Recommendation Trends

Rating
Mar 24
May 24
Aug 24
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
3
3
3
2
1
Hold
0
0
0
3
3
Sell
0
0
0
1
2
Strong Sell
0
0
0
0
0
total
3
3
3
6
6
In the current month, ISPC has received 1 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. ISPC average Analyst price target in the past 3 months is 1.00.
Each month's total comprises the sum of three months' worth of ratings.

ISPC Stock Forecast FAQ

What is ISPC’s average 12-month price target, according to analysts?
Based on analyst ratings, iSpecimen’s 12-month average price target is 1.00.
    What is ISPC’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for ISPC, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is ISPC a Buy, Sell or Hold?
        iSpecimen has a consensus rating of Moderate Sell which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is iSpecimen’s price target?
          The average price target for iSpecimen is 1.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents -7.41% Decrease from the current price of $1.08.
            What do analysts say about iSpecimen?
            iSpecimen’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of ISPC?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis